Different Types of Dementia

Learn the signs, symptoms, and causes of Alzheimer disease, vascular, Lewy body, frontotemporal, and Parkinson disease dementias.

25 minutes

Start Lesson

Lesson Outline


Dementia is a general term for a decline in cognitive function severe enough to interfere with daily life. It is most commonly caused by toxic proteins or blood vessel damage in the brain, or a mix of those causes. The symptoms and signs of dementia can vary based on the cause and the area of the brain affected.


After completing this interactive lesson, you should be able to answer the following questions:

  • What are the most common diseases that cause dementia?
  • What are the signs and symptoms of each type?
  • How do they progress?
25 minutes

Start Lesson

⏱ 3 min read

Different types of dementia

It is often difficult to distinguish between the different types of dementia, and many people may have a mix of more than one type. There is no easy way to make a definite diagnosis, as there is not necessarily one clear test to confirm it. Signs and symptoms may change or evolve over time, leading to changes in the most likely underlying diagnosis or cause of the dementia.


Alzheimer disease

Alzheimer disease is the most common cause of dementia, accounting for the majority of cases. The risk of developing Alzheimer disease increases with age, typically starting in the 70s or 80s. The disease most commonly progresses steadily and gradually, leading to a decline in memory, learning, and other cognitive functions over several years.

The toxic proteins involved in Alzheimer disease, such as amyloid beta, tend to damage parts of the brain related to memory and learning, particularly the middle temporal lobes and hippocampus. This results in short-term memory problems, where individuals may remember past events but struggle to recall recent occurrences.

Common symptoms include:

  • Short-term memory problems (e.g., repeating stories, missing appointments)
  • Visual and spatial issues (e.g., getting lost, misjudging distances)
  • Language difficulties (e.g., word finding, understanding complex explanations)
  • Certain movement problems (e.g., difficulty with tasks like buttoning shirts)
  • Thinking problems (e.g., difficulty with multitasking, planning)
  • Behavioural and psychological issues (e.g., apathy, depression, paranoia)

Vascular dementia

Vascular dementia is the second most common type of dementia, caused by slow and steady damage to small blood vessels in the brain or by strokes. The cognitive decline can happen immediately after a stroke or gradually over time. Up to one-third of people who have a stroke develop permanent cognitive problems.

The symptoms of vascular dementia depend on the location of the brain damage and can include:

  • Poor executive function (e.g., trouble planning and organizing)
  • Complex attention difficulties (e.g., easily distracted)
  • Slowness of thinking
  • Emotional extremes and quick mood changes
  • Decreased motivation (apathy)
  • Memory retrieval issues

Unlike Alzheimer disease, people with vascular dementia can often make new memories but may have difficulty retrieving them. The progression of vascular dementia can be sudden or gradual, often showing a stepwise pattern of decline.


Dementia with Lewy bodies

Dementia with Lewy bodies results from the build-up of abnormal proteins (Lewy bodies) in the brain and typically develops in individuals in their mid-70s and progresses gradually. It shares symptoms with both Alzheimer and Parkinson diseases.

Symptoms include:

  • Fluctuating alertness and cognitive function
  • Visual hallucinations
  • Parkinsonism (e.g., tremor, muscle stiffness)
  • Sleep disorders
  • Repeated falls and fainting
  • Sensitivity to antipsychotic medications

Differentiating dementia with Lewy bodies from Parkinson disease dementia can be challenging due to overlapping motor symptoms. Generally, cognitive problems appear first in dementia with Lewy bodies, whereas the motor symptoms appear much earlier in Parkinson disease dementia.


Parkinson disease dementia

Parkinson disease dementia occurs in individuals with Parkinson disease, typically many years after the initial diagnosis. The cognitive decline follows the onset of Parkinson’s motor symptoms, such as slowness of movement and difficulty starting movements.

Symptoms include:

  • Slowness of thought and speech
  • Impaired executive function
  • Decreased motivation (apathy)
  • Depressed mood and anxiety
  • Hallucinations and delusions
  • Sleep-related behaviours and daytime sleepiness

The cognitive problems in Parkinson disease dementia continue to worsen gradually over time.


Frontotemporal dementia

Frontotemporal dementia results from the accumulation of toxic proteins in the frontal and temporal lobes of the brain, leading to significant changes in personality and behaviour. The disease typically presents in individuals in their 50s or 60s and the rate of progression can vary depending on the subtype and person, though it usually progresses more rapidly than Alzheimer disease.

Symptoms include:

  • Changes in personality and behaviour (e.g., inappropriate actions, lack of empathy)
  • Language difficulties
  • Obsessive or repetitive behaviours
  • Increased need to eat, hyperorality
  • Loss of motivation (apathy)

Mixed dementia

Mixed dementia is a combination of two or more types of dementia, with Alzheimer disease and vascular dementia being a common combination. The symptoms of mixed dementia vary depending on the types involved, and the progression can be more complex due to the presence of multiple types of brain changes. Diagnosing mixed dementia can be challenging, as there is often no clear test to confirm the diagnosis, and symptoms may change or evolve over time.

Lesson Summary

A written summary of this topic.

Download

Micro-Learning

Sign up for a 5-week email-based series on dementia.

Sign Up


Sign up for a 4-week email-based series on mild cognitive impairment.

Sign Up

Quiz

Think you know about dementia? 

Take Quiz

Survey

Tell us what you think about this content with a quick 3-item survey. Your participation will help us improve this resource.

Take Survey

Want to learn more about how to promote brain health?

Explore our content on dementia risk reduction.

Learn More

What would you like to do next?


Brain with cognitive impairment

Dementia: An Overview

Learn the basics of dementia, including causes, symptoms, stages, treatments, safety issues, caregiver wellness and supports, and how to promote brain health. (12 minutes)

Start Lesson

3-D dark brain signifying dementia with cogs representing cognition

What is Dementia?

Explore what cognition is and how it is impacted by dementia. Learn the common causes and other possible causes of dementia-like symptoms. (15 minutes)

Start Lesson

3-D brain with some areas of darkness signifying mild cognitive impairment

What is Mild Cognitive Impairment?

Understand the difference between normal aging and mild cognitive impairment, its causes, diagnosis, management, treatment, and steps to take after a diagnosis. (20 minutes)

Start Lesson

3-D dark brain signifying dementia with pill bottle and bandaids for treatment

How is Dementia Treated?

Explore how to manage dementia's cognitive, behavioural, emotional and psychiatric symptoms and how disease modification strategies address its underlying causes. (20 minutes)

Start Lesson

Authors

Anthony Levinson

Anthony J. Levinson, MD, MSc, FRCPC

Neuropsychiatrist, Professor; Faculty of Health Sciences, McMaster University

Dr. Richard Sztramko

Richard Sztramko, MD, FRCPC

Consultant Geriatrician and Internist, Vancouver Coastal Health

About this Project

Who authored and edited this page?

This page was developed by the Division of e-Learning Innovation team and Dr. Anthony J. Levinson, MD, FRCPC (Psychiatry) and Dr. Richard Sztramko, MD, FRCPC (Internal Medicine, Geriatrics). 

Dr. Levinson is a psychiatrist and professor in the Department of Psychiatry and Behaviour Neurosciences, Faculty of Health Sciences, McMaster University. He is the Director of the Division of e-Learning Innovation, as well as the John Evans Chair in Health Sciences Educational Research at McMaster. He practices Consultation-Liaison Psychiatry, with a special focus on dementia and other cognitive and mental disorders in the medically ill. He is also the co-developer, along with Dr. Sztramko, of the iGeriCare.ca dementia care partner resource, and one of the co-leads for the McMaster Optimal Aging Portal. He and his team are passionate about developing high-quality digital content to improve people's understanding about health. 

Dr. Sztramko is a consultant geriatrician and internist for Vancouver Coastal Health who also completed a fellowship in Behavioural Neurology at the University of California San Francisco (UCSF). Through his work with patients with dementia and their families, Dr. Sztramko came to understand that there is a desire and need for online education about dementia that has been developed by experts in geriatrics. This inspired him to pursue the creation of iGeriCare, on which this content is based.

A team of experts in geriatrics and mental health reviewed the content for accuracy, and care partners of people living with dementia participated in the design and development of the content on iGeriCare.

Are there any important disclosures or conflicts of interest?

Dr. Levinson receives funding from McMaster University as part of his research chair. He has also received several grants for his work from not-for-profit granting agencies. He has no conflicts of interest with respect to the pharmaceutical industry; and there were no funds from industry used in the development of this content or website.

Dr. Sztramko has no conflicts of interest to disclose with respect to development of this content.

When was it last reviewed?

November 29, 2024.

What references and evidence were used to create this content?

The content was written and adapted by experts in geriatrics and neuropsychiatry based on credible, high-quality, evidence-based sources such as the National Institute on Aging, National Institute of Neurological Disorders and Stroke, American Academy of Neurology, National Institutes of Health, the American Psychiatric Association and the DSM-5 TR (2022), Health Quality Ontario quality standards, Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia (2020), the Cochrane Library, the Alzheimer Society of Canada, UptoDate®, the World Health Organization (WHO), and others.

Who funded it?

The initial development of some of this content was funded by the Centre for Aging and Brain Health Innovation (CABHI), powered by Baycrest, along with additional support from the Hamilton Health Sciences Foundation and Geras Centre for Aging Research. Subsequent funding was through support from the McMaster Optimal Aging Portal, with support from the Labarge Optimal Aging Initiative, the Faculty of Health Sciences, and the McMaster Institute for Research on Aging (MIRA) at McMaster University. There are no conflicts of interest to declare. There was no industry funding for this content.